One World Products (OWPC) Net Income towards Common Stockholders (2014 - 2025)
One World Products (OWPC) recorded quarterly Net Income towards Common Stockholders of $5.3 million in Q3 2025, up 1970.86% quarter-over-quarter from -$280673.0 in Q2 2025, and up 800.43% on a YoY basis from $583165.3 in Q3 2024.
One World Products (OWPC) Net Income towards Common Stockholders (2014 - 2025) Analysis & Trends
One World Products' Net Income towards Common Stockholders history runs 12 years deep, the most recent figure standing at $5.3 million for Q3 2025.
- In Q3 2025, Net Income towards Common Stockholders rose 800.43% year-over-year to $5.3 million; the TTM figure through Sep 2025 stood at $4.1 million (up 168.71% YoY), while the FY2024 annual figure was -$4.0 million, down 3.01% from the prior year.
- Net Income towards Common Stockholders was $5.3 million for Q3 2025 at One World Products, up from -$280673.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $5.3 million in Q3 2025 to a low of -$2.5 million in Q4 2023.
- Historically, Net Income towards Common Stockholders has averaged -$535467.1 across 5 years, with a median of -$712669.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders plunged 411.51% in 2024, then surged 800.43% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.3 million in 2021, then surged by 42.58% to -$767448.0 in 2022, then slumped by 226.72% to -$2.5 million in 2023, then jumped by 74.1% to -$649415.0 in 2024, then surged by 908.57% to $5.3 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at $5.3 million (Q3 2025), -$280673.0 (Q2 2025), and -$270423.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | One World Products | - | - | 48,591.00 | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.25 Mn |
| Jun 30, 2025 | -280,673.00 |
| Mar 31, 2025 | -270,423.00 |
| Dec 31, 2024 | -649,415.00 |
| Sep 30, 2024 | -749,682.00 |
| Jun 30, 2024 | -879,975.00 |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | -2.51 Mn |
| Sep 30, 2023 | -498,220.00 |
| Jun 30, 2023 | -569,850.00 |
| Mar 31, 2023 | -343,742.00 |
| Dec 31, 2022 | -767,448.00 |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | -712,669.00 |
| Mar 31, 2022 | -602,960.00 |
| Dec 31, 2021 | -1.34 Mn |
| Sep 30, 2021 | -687,582.00 |
| Jun 30, 2021 | -746,357.00 |
| Mar 31, 2021 | -1.06 Mn |
| Dec 31, 2020 | -2.78 Mn |